Campistol JM - Search Results

1

The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation.

Xipell M, Rodas LM, Villarreal J, Molina A, Reinoso-Moreno J, Blasco M, Poch E, Diekmann F, Campistol JM, Quintana LF. Xipell M, et al. Among authors: campistol jm. Clin Kidney J. 2018 Jun;11(3):422-428. doi: 10.1093/ckj/sfx128. Epub 2017 Nov 22. Clin Kidney J. 2018. PMID: 29988247 Free PMC article.

2

[Kt as control and follow-up of the dose at a hemodialysis unit].

Maduell F, Vera M, Serra N, Collado S, Carrera M, Fernández A, Arias M, Blasco M, Burgadá E, Cases A, Campistol JM. Maduell F, et al. Among authors: campistol jm. Nefrologia. 2008;28(1):43-7. Nefrologia. 2008. PMID: 18336130 Free article. Spanish.

3

Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.

Rabasco C, Cavero T, Román E, Rojas-Rivera J, Olea T, Espinosa M, Cabello V, Fernández-Juarez G, González F, Ávila A, Baltar JM, Díaz M, Alegre R, Elías S, Antón M, Frutos MA, Pobes A, Blasco M, Martín F, Bernis C, Macías M, Barroso S, de Lorenzo A, Ariceta G, López-Mendoza M, Rivas B, López-Revuelta K, Campistol JM, Mendizábal S, de Córdoba SR, Praga M; Spanish Group for the Study of Glomerular Diseases (GLOSEN). Rabasco C, et al. Among authors: campistol jm. Kidney Int. 2015 Nov;88(5):1153-60. doi: 10.1038/ki.2015.227. Epub 2015 Jul 29. Kidney Int. 2015. PMID: 26221755 Free article.

4

Set point of calcium in severe secondary hyperparathyroidism is altered and does not change after successful kidney transplantation.

Torregrosa JV, Fuster D, Duran CE, Oppenheimer F, Muxí Á, Rubello D, Pons F, Campistol JM. Torregrosa JV, et al. Among authors: campistol jm. Endocrine. 2015 Mar;48(2):709-11. doi: 10.1007/s12020-014-0312-0. Epub 2014 Jun 27. Endocrine. 2015. PMID: 24965230 No abstract available.

5

Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.

Bergua C, Torregrosa JV, Fuster D, Gutierrez-Dalmau A, Oppenheimer F, Campistol JM. Bergua C, et al. Among authors: campistol jm. Transplantation. 2008 Aug 15;86(3):413-7. doi: 10.1097/TP.0b013e31817c13e1. Transplantation. 2008. PMID: 18698244 Clinical Trial.

6

Toxoplasma gondii primary infection in renal transplant recipients. Two case reports and literature review.

Martina MN, Cervera C, Esforzado N, Linares L, Torregrosa V, Sanclemente G, Hoyo I, Cofan F, Oppenheimer F, Miro JM, Campistol JM, Moreno A. Martina MN, et al. Among authors: campistol jm. Transpl Int. 2011 Jan;24(1):e6-12. doi: 10.1111/j.1432-2277.2010.01173.x. Epub 2010 Oct 19. Transpl Int. 2011. PMID: 20955469 Free article. Review.

7

Bioimpedance-guided fluid management in hemodialysis patients.

Moissl U, Arias-Guillén M, Wabel P, Fontseré N, Carrera M, Campistol JM, Maduell F. Moissl U, et al. Among authors: campistol jm. Clin J Am Soc Nephrol. 2013 Sep;8(9):1575-82. doi: 10.2215/CJN.12411212. Epub 2013 Aug 15. Clin J Am Soc Nephrol. 2013. PMID: 23949235 Free PMC article.

8

Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial.

Praga M, Andrade CF, Luño J, Arias M, Poveda R, Mora J, Prat MV, Rivera F, Galceran JM, Ara JM, Aguirre R, Bernis C, Marín R, Campistol JM. Praga M, et al. Among authors: campistol jm. Nephrol Dial Transplant. 2003 Sep;18(9):1806-13. doi: 10.1093/ndt/gfg284. Nephrol Dial Transplant. 2003. PMID: 12937228 Clinical Trial.

9

Effect of thymoglobulin induction on HIV-infected renal transplant recipients: differences between HIV-positive and HIV-negative patients.

Trullas JC, Cofan F, Cocchi S, Cervera C, Linares L, Aguero F, Oppenheimer F, Moreno A, Campistol JM, Miró JM. Trullas JC, et al. Among authors: campistol jm. AIDS Res Hum Retroviruses. 2007 Oct;23(10):1161-5. doi: 10.1089/aid.2007.0015. AIDS Res Hum Retroviruses. 2007. PMID: 17961099

10

KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients.

Tavira B, Coto E, Díaz-Corte C, Ortega F, Arias M, Torres A, Díaz JM, Selgas R, López-Larrea C, Campistol JM, Ruiz-Ortega M, Alvarez V; Pharmacogenetics of Tacrolimus REDINREN Study Group. Tavira B, et al. Among authors: campistol jm. Clin Transplant. 2011 May-Jun;25(3):E284-91. doi: 10.1111/j.1399-0012.2011.01417.x. Epub 2011 Mar 1. Clin Transplant. 2011. PMID: 21355884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

541 results

Search Page